BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27599036)

  • 1. A Novel Role for Progesterone Receptor Membrane Component 1 (PGRMC1): A Partner and Regulator of Ferrochelatase.
    Piel RB; Shiferaw MT; Vashisht AA; Marcero JR; Praissman JL; Phillips JD; Wohlschlegel JA; Medlock AE
    Biochemistry; 2016 Sep; 55(37):5204-17. PubMed ID: 27599036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of progesterone receptor membrane component-1 as an interaction partner and possible regulator of fatty acid 2-hydroxylase.
    Hardt R; Winter D; Gieselmann V; Eckhardt M
    Biochem J; 2018 Mar; 475(5):853-871. PubMed ID: 29438993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone receptor membrane component 1 (Pgrmc1): a heme-1 domain protein that promotes tumorigenesis and is inhibited by a small molecule.
    Ahmed IS; Rohe HJ; Twist KE; Mattingly MN; Craven RJ
    J Pharmacol Exp Ther; 2010 May; 333(2):564-73. PubMed ID: 20164297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progesterone receptor membrane component 1 (PGRMC1) binds and stabilizes cytochromes P450 through a heme-independent mechanism.
    McGuire MR; Mukhopadhyay D; Myers SL; Mosher EP; Brookheart RT; Kammers K; Sehgal A; Selen ES; Wolfgang MJ; Bumpus NN; Espenshade PJ
    J Biol Chem; 2021 Nov; 297(5):101316. PubMed ID: 34678314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferrochelatase forms an oligomeric complex with mitoferrin-1 and Abcb10 for erythroid heme biosynthesis.
    Chen W; Dailey HA; Paw BH
    Blood; 2010 Jul; 116(4):628-30. PubMed ID: 20427704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PGRMC1 (progesterone receptor membrane component 1): a targetable protein with multiple functions in steroid signaling, P450 activation and drug binding.
    Rohe HJ; Ahmed IS; Twist KE; Craven RJ
    Pharmacol Ther; 2009 Jan; 121(1):14-9. PubMed ID: 18992768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progesterone receptor membrane component 1: an integrative review.
    Cahill MA
    J Steroid Biochem Mol Biol; 2007; 105(1-5):16-36. PubMed ID: 17583495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thoughts on interactions between PGRMC1 and diverse attested and potential hydrophobic ligands.
    Cahill MA; Medlock AE
    J Steroid Biochem Mol Biol; 2017 Jul; 171():11-33. PubMed ID: 28104494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic Analysis of Ferrochelatase Interactome in Erythroid and Non-Erythroid Cells.
    Obi CD; Dailey HA; Jami-Alahmadi Y; Wohlschlegel JA; Medlock AE
    Life (Basel); 2023 Feb; 13(2):. PubMed ID: 36836934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging role of progesterone receptor membrane component 1 (PGRMC1) in cancer biology.
    Cahill MA; Jazayeri JA; Catalano SM; Toyokuni S; Kovacevic Z; Richardson DR
    Biochim Biophys Acta; 2016 Dec; 1866(2):339-349. PubMed ID: 27452206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conditional Ablation of Progesterone Receptor Membrane Component 2 Causes Female Premature Reproductive Senescence.
    Clark NC; Pru CA; Yee SP; Lydon JP; Peluso JJ; Pru JK
    Endocrinology; 2017 Mar; 158(3):640-651. PubMed ID: 28005395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Spectroscopic and mutagenesis studies of human PGRMC1.
    Kaluka D; Batabyal D; Chiang BY; Poulos TL; Yeh SR
    Biochemistry; 2015 Mar; 54(8):1638-47. PubMed ID: 25675345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestin and AdipoQ Receptor 7, Progesterone Membrane Receptor Component 1 (PGRMC1), and PGRMC2 and Their Role in Regulating Progesterone's Ability to Suppress Human Granulosa/Luteal Cells from Entering into the Cell Cycle.
    Sueldo C; Liu X; Peluso JJ
    Biol Reprod; 2015 Sep; 93(3):63. PubMed ID: 26203174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FAM210B is an erythropoietin target and regulates erythroid heme synthesis by controlling mitochondrial iron import and ferrochelatase activity.
    Yien YY; Shi J; Chen C; Cheung JTM; Grillo AS; Shrestha R; Li L; Zhang X; Kafina MD; Kingsley PD; King MJ; Ablain J; Li H; Zon LI; Palis J; Burke MD; Bauer DE; Orkin SH; Koehler CM; Phillips JD; Kaplan J; Ward DM; Lodish HF; Paw BH
    J Biol Chem; 2018 Dec; 293(51):19797-19811. PubMed ID: 30366982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transcriptional regulation of the expression of ferrochelatase by its variant mRNA.
    Sakaino M; Kataoka T; Taketani S
    J Biochem; 2009 Jun; 145(6):733-8. PubMed ID: 19251765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ubiquitous mitochondrial protein unfoldase CLPX regulates erythroid heme synthesis by control of iron utilization and heme synthesis enzyme activation and turnover.
    Rondelli CM; Perfetto M; Danoff A; Bergonia H; Gillis S; O'Neill L; Jackson L; Nicolas G; Puy H; West R; Phillips JD; Yien YY
    J Biol Chem; 2021 Aug; 297(2):100972. PubMed ID: 34280433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The C-terminal extension of ferrochelatase is critical for enzyme activity and for functioning of the tetrapyrrole pathway in Synechocystis strain PCC 6803.
    Sobotka R; McLean S; Zuberova M; Hunter CN; Tichy M
    J Bacteriol; 2008 Mar; 190(6):2086-95. PubMed ID: 18192382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salicylic acid induces mitochondrial injury by inhibiting ferrochelatase heme biosynthesis activity.
    Gupta V; Liu S; Ando H; Ishii R; Tateno S; Kaneko Y; Yugami M; Sakamoto S; Yamaguchi Y; Nureki O; Handa H
    Mol Pharmacol; 2013 Dec; 84(6):824-33. PubMed ID: 24043703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PGRMC1: An enigmatic heme-binding protein.
    McGuire MR; Espenshade PJ
    Pharmacol Ther; 2023 Jan; 241():108326. PubMed ID: 36463977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progesterone Receptor Membrane Component 1 and its Accomplice: Emerging Therapeutic Targets in Lung Cancer.
    Solairaja S; Ramalingam S; Dunna NR; Venkatabalasubramanian S
    Endocr Metab Immune Disord Drug Targets; 2022; 22(6):601-611. PubMed ID: 34847852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.